olmesartan medoxomil amlodipine and hydrochlorothiazide
Generic: olmesartan medoxomil amlodipine and hydrochlorothiazide
Labeler: macleods pharmaceuticals limitedDrug Facts
Product Profile
Brand Name
olmesartan medoxomil amlodipine and hydrochlorothiazide
Generic Name
olmesartan medoxomil amlodipine and hydrochlorothiazide
Labeler
macleods pharmaceuticals limited
Dosage Form
TABLET, FILM COATED
Routes
Active Ingredients
amlodipine besylate 5 mg/1, hydrochlorothiazide 12.5 mg/1, olmesartan medoxomil 20 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
33342-243
Product ID
33342-243_52c013e1-8c31-4bed-9241-e7845873ebe8
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA207088
Listing Expiration
2026-12-31
Marketing Start
2025-07-18
Pharmacologic Class
Established (EPC)
Chemical Structure
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
33342243
Hyphenated Format
33342-243
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
olmesartan medoxomil amlodipine and hydrochlorothiazide (source: ndc)
Generic Name
olmesartan medoxomil amlodipine and hydrochlorothiazide (source: ndc)
Application Number
ANDA207088 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 5 mg/1
- 12.5 mg/1
- 20 mg/1
Packaging
- 30 TABLET, FILM COATED in 1 BOTTLE (33342-243-07)
- 90 TABLET, FILM COATED in 1 BOTTLE (33342-243-10)
Packages (2)
Ingredients (3)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "52c013e1-8c31-4bed-9241-e7845873ebe8", "openfda": {"nui": ["N0000175359", "N0000175419", "M0471776"], "upc": ["0333342247070", "0333342245076"], "unii": ["0J48LPH2TH", "864V2Q084H", "6M97XTV3HD"], "rxcui": ["999967", "999986", "999991", "999996", "1000001"], "spl_set_id": ["52c013e1-8c31-4bed-9241-e7845873ebe8"], "pharm_class_cs": ["Thiazides [CS]"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]"], "manufacturer_name": ["Macleods Pharmaceuticals Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (33342-243-07)", "package_ndc": "33342-243-07", "marketing_start_date": "20250718"}, {"sample": false, "description": "90 TABLET, FILM COATED in 1 BOTTLE (33342-243-10)", "package_ndc": "33342-243-10", "marketing_start_date": "20250718"}], "brand_name": "Olmesartan medoxomil Amlodipine and Hydrochlorothiazide", "product_id": "33342-243_52c013e1-8c31-4bed-9241-e7845873ebe8", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Angiotensin 2 Receptor Antagonists [MoA]", "Angiotensin 2 Receptor Blocker [EPC]", "Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Dihydropyridine Calcium Channel Blocker [EPC]", "Dihydropyridines [CS]", "Increased Diuresis [PE]", "Thiazide Diuretic [EPC]", "Thiazides [CS]"], "product_ndc": "33342-243", "generic_name": "Olmesartan medoxomil Amlodipine and Hydrochlorothiazide", "labeler_name": "Macleods Pharmaceuticals Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Olmesartan medoxomil Amlodipine and Hydrochlorothiazide", "active_ingredients": [{"name": "AMLODIPINE BESYLATE", "strength": "5 mg/1"}, {"name": "HYDROCHLOROTHIAZIDE", "strength": "12.5 mg/1"}, {"name": "OLMESARTAN MEDOXOMIL", "strength": "20 mg/1"}], "application_number": "ANDA207088", "marketing_category": "ANDA", "marketing_start_date": "20250718", "listing_expiration_date": "20261231"}